000 01207 a2200349 4500
005 20250517180016.0
264 0 _c20190205
008 201902s 0 0 eng d
022 _a1728-7731
024 7 _a10.1016/j.jcma.2017.07.008
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWang, Shu-Chi
245 0 0 _aPathological outcomes in men with prostate cancer who are eligible for active surveillance.
_h[electronic resource]
260 _bJournal of the Chinese Medical Association : JCMA
_c04 2018
300 _a348-351 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Grading
650 0 4 _aProstate-Specific Antigen
_xblood
650 0 4 _aProstatectomy
650 0 4 _aProstatic Neoplasms
_xpathology
650 0 4 _aRetrospective Studies
700 1 _aChen, Cheng-Che
700 1 _aYang, Cheng-Kuang
700 1 _aHung, Siu-Wan
700 1 _aJan, Yee-Jee
700 1 _aOu, Yen-Chuan
773 0 _tJournal of the Chinese Medical Association : JCMA
_gvol. 81
_gno. 4
_gp. 348-351
856 4 0 _uhttps://doi.org/10.1016/j.jcma.2017.07.008
_zAvailable from publisher's website
999 _c27641857
_d27641857